Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR) Director Harold Morton Wolkin sold 3,500 shares of the company’s stock in a transaction on Monday, March 24th. The shares were sold at an average price of C$13.49, for a total transaction of C$47,215.00.
Cipher Pharmaceuticals Price Performance
Shares of CPH opened at C$12.32 on Wednesday. The company has a debt-to-equity ratio of 41.22, a current ratio of 2.00 and a quick ratio of 2.67. Cipher Pharmaceuticals Inc. has a 1-year low of C$7.90 and a 1-year high of C$19.69. The stock has a market cap of C$221.18 million, a PE ratio of 13.61 and a beta of 1.20. The firm has a fifty day moving average price of C$12.85 and a 200 day moving average price of C$14.38.
About Cipher Pharmaceuticals
Featured Articles
- Five stocks we like better than Cipher Pharmaceuticals
- How to Calculate Stock Profit
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Retail Stocks Investing, Explained
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- How to Use the MarketBeat Dividend Calculator
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.